Post

🎗️ Tomorrow is #WorldLungCancerDay. A recent Lung Cancer publication shows that the EORTC QLQ-C30 and QLQ-LC29 capture many common patient-reported symptomatic adverse events in #NSCLC, supporting the use of PROs alongside clinician-reported assessments. www.eortc.org/publications/ @qol.eortc.org